🔎 Trials Near Me

Akèy › Kansè renn (Kasinom selil renn) › New York › Queens

Etid klinik pou Kansè renn (Kasinom selil renn) nan Queens, NY

15 etid pou Kansè renn (Kasinom selil renn) ap chèche patisipan nan sit nan ak bò kote Queens (nan yon distans apeprè 30 mil). Louvri yon etid pou wè ki moun ki ka patisipe ak kijan pou kontakte ekip etid la.

Tèks ofisyèl etid la (Anglè)

Ap chèche patisipan pou yon etid? Mete l anwo paj sa a — $99 pou 30 jou →

Open-Label Phase 1/2 Study of NEO-811 in Subjects With Locally Advanced or Metastatic Non-Resectable Clear Cell Renal Cell Carcinoma

Ap rekriteFaz 1
  • NEO-811 Long Island Site, Lake Success · 9 mi lwen
Laj 18 ak plis · Tout sèks · Mizajou Oct 5, 2026 · NCT07300241

A Phase 1 Study of PLN-101095 in Adults With Advanced or Metastatic Solid Tumors

Ap rekriteFaz 1
  • START New York Long Island LLC, Lake Success · 9 mi lwen
Laj 18 ak plis · Tout sèks · Mizajou Oct 2, 2026 · NCT06270706

A Phase 1 Study of the Safety and Tolerability of CTX-10726

Ap rekriteFaz 1
  • START New York, Lake Success · 9 mi lwen
Laj 18 ak plis · Tout sèks · Mizajou Oct 2, 2026 · NCT07419841

Substudy 03C: A Study of Combination Therapies in Participants With Renal Cell Carcinoma With Recurrent Disease During or After Anti-PD-(L)1 Therapy (MK-3475-03C/KEYMAKER-U03)

Ap rekriteFaz 1/2
  • Perlmutter Cancer Center at NYU Langone Hospital - Long Island ( Site 5026), Mineola · 11 mi lwen
Laj 18 a 120 · Tout sèks · Mizajou Oct 2, 2026 · NCT07049926

Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection

Ap rekriteEtid obsèvasyonVolontè an sante akeyi
  • Queens Hospital Center, Jamaica · 2 mi lwen
Laj 40 a 75 · Tout sèks · Mizajou Oct 2, 2026 · NCT05334069

Testing the Effectiveness of Two Immunotherapy Drugs (Nivolumab and Ipilimumab) With One Anti-cancer Targeted Drug (Cabozantinib) for Rare Genitourinary Tumors

Ap rekriteFaz 2
  • Memorial Sloan Kettering Nassau, Uniondale · 13 mi lwen
Laj 18 ak plis · Tout sèks · Mizajou Sep 30, 2026 · NCT03866382

Testing the Addition of Stereotactic Radiation Therapy With Immune Therapy for the Treatment of Patients With Unresectable or Metastatic Renal Cell Cancer, SAMURAI Trial

Ap rekriteFaz 2
  • Northwell Health/Center for Advanced Medicine, Lake Success · 9 mi lwen
  • Memorial Sloan Kettering Nassau, Uniondale · 13 mi lwen
Laj 18 ak plis · Tout sèks · Mizajou Sep 18, 2026 · NCT05327686

Testing the Addition of the Anti-Cancer Drug Tivozanib to Immunotherapy (Pembrolizumab) After Surgery to Remove All Known Sites of Kidney Cancer

Ap rekriteFaz 3
  • Northwell Health/Center for Advanced Medicine, Lake Success · 9 mi lwen
  • Memorial Sloan Kettering Nassau, Uniondale · 13 mi lwen
Laj 18 ak plis · Tout sèks · Mizajou Sep 2, 2026 · NCT06661720

A Study of Radiation Therapy to Treat Solid Tumor Cancer That Has Spread to Soft Tissue

Ap rekrite
  • Memorial Sloan Kettering Nassau (Limited protocol activities), Rockville Centre · 10 mi lwen
Laj 18 ak plis · Tout sèks · Mizajou Sep 2, 2026 · NCT05837767

A Study of MGC026 in Participants With Advanced Solid Tumors

Ap rekriteFaz 1
  • START-New York Long Island, Lake Success · 9 mi lwen
Laj 18 ak plis · Tout sèks · Mizajou Aug 11, 2026 · NCT06242470

A Study of Abemaciclib and Cabozantinib in People With Clear Cell Renal Cell Carcinoma (ccRCC)

Ap rekriteFaz 1/2
  • Memorial Sloan Kettering Nassau (Limited Protocol Activities), Uniondale · 13 mi lwen
Laj 18 ak plis · Tout sèks · Mizajou Jun 24, 2026 · NCT06835972

A Study of Cemiplimab and Fianlimab in People With Clear Cell Renal Cell Carcinoma

Ap rekriteFaz 2
  • Memorial Sloan Kettering Nassau (Limited Protocol Activities), Uniondale · 13 mi lwen
Laj 18 ak plis · Tout sèks · Mizajou Mar 4, 2026 · NCT06699602

Comparing the Outcome of Immunotherapy-Based Drug Combination Therapy With or Without Surgery to Remove the Kidney in Metastatic Kidney Cancer, the PROBE Trial

Ap rekriteFaz 3
  • Northwell Health/Center for Advanced Medicine, Lake Success · 9 mi lwen
Laj 18 ak plis · Tout sèks · Mizajou Sep 9, 2025 · NCT04510597

Etid Kansè renn (Kasinom selil renn) nan lòt vil

Lòt etid nan Queens

Sous ClinicalTrials.gov, done yo ranmase Oct 6, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.